Drawing for DERMAQUANT

USPTO serial 86442129

DERMAQUANT

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
SALEMI, DOMINICK
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with DERMAQUANT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
010Electronic medical appliances for wound healing; Medical apparatus and instruments for monitoring blood properties and respiratory events; Medical apparatus and instruments for monitoring oxymetory, gas analysis and vital signs; Medical apparatus and instruments for monitoring oxymetory, gas analysis, vital signs, blood properties and respiratory events; Medical apparatus and instruments for monitoring oxymetory, gas analysis, vital signs, blood properties and respiratory events and software sold therewith as a unit; Medical apparatus and instruments for monitoring vital signs, blood properties and respiratory events; Medical devices for monitoring oxymetory, gas analysis and vital signs; Medical devices for monitoring oxymetory, gas analysis, vital signs, blood properties and respiratory events; Medical devices for monitoring oxymetory, gas analysis, vital signs, blood properties and respiratory events and software sold as a unit therewith; Medical devices for monitoring oxymetory, gas analysis, vital signs, blood properties and respiratory events and system that transmit the data through the Internet; Medical devices for monitoring vital signs, blood properties and respiratory events; Medical devices, namely, devices for measuring wounds; Medical instruments for measuring and displaying blood oxigenationACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jan 4, 2016MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jan 4, 2016ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 2, 2015NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 7, 2015NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 7, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 18, 2015NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 23, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 23, 2015DOCKASSIGNED TO EXAMINER—
Nov 13, 2014NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 5, 2014NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance